Treatment of neutropenia with intravenous immunoglobulin in autoimmune neutropenia of childhood

S. H. Chen, D. C. Liang, H. C. Liu, M. Lin

Research output: Contribution to journalArticle

Abstract

Five patients (2 boys, 3 girls) with autoimmune neutropenia (AIN) which developed mainly in infancy were treated with intravenous immunoglobulin (IVIG) and followed up for 69-95 months. AIN was proved by positive antineutrophil antibodies detected by a granulocyte agglutination test. Of these five patients, three patients experienced septicemia prior to treatment. These patients also had several episodes of upper respiratory tract infection, acute otitis media, skin infection and enterocolitis. Basically, IVIG 2 g/kg was given intravenously for each course of treatment. The neutrophil counts increased significantly in all patients with the initial IVIG therapy and two patients went into remission. Subsequent infusions also caused neutrophil counts to increase. Although many patients with AIN have a benign course, those who have significant infections could be treated, acutely or preventively, with IVIG.

Original languageEnglish
Pages (from-to)347-353
Number of pages7
JournalInternational Journal of Pediatric Hematology/Oncology
Volume6
Issue number5
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Intravenous Immunoglobulins
Neutropenia
Therapeutics
Neutrophils
Enterocolitis
Agglutination Tests
Passive Immunization
Otitis Media
Infection
Granulocytes
Respiratory Tract Infections
Sepsis
Skin
Antibodies

Keywords

  • Autoimmune neutropenia
  • Intravenous immunoglobulin
  • IVIG

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Pediatrics, Perinatology, and Child Health

Cite this

Treatment of neutropenia with intravenous immunoglobulin in autoimmune neutropenia of childhood. / Chen, S. H.; Liang, D. C.; Liu, H. C.; Lin, M.

In: International Journal of Pediatric Hematology/Oncology, Vol. 6, No. 5, 2000, p. 347-353.

Research output: Contribution to journalArticle

@article{8b13112bd7154cb796c95b4dcbf60826,
title = "Treatment of neutropenia with intravenous immunoglobulin in autoimmune neutropenia of childhood",
abstract = "Five patients (2 boys, 3 girls) with autoimmune neutropenia (AIN) which developed mainly in infancy were treated with intravenous immunoglobulin (IVIG) and followed up for 69-95 months. AIN was proved by positive antineutrophil antibodies detected by a granulocyte agglutination test. Of these five patients, three patients experienced septicemia prior to treatment. These patients also had several episodes of upper respiratory tract infection, acute otitis media, skin infection and enterocolitis. Basically, IVIG 2 g/kg was given intravenously for each course of treatment. The neutrophil counts increased significantly in all patients with the initial IVIG therapy and two patients went into remission. Subsequent infusions also caused neutrophil counts to increase. Although many patients with AIN have a benign course, those who have significant infections could be treated, acutely or preventively, with IVIG.",
keywords = "Autoimmune neutropenia, Intravenous immunoglobulin, IVIG",
author = "Chen, {S. H.} and Liang, {D. C.} and Liu, {H. C.} and M. Lin",
year = "2000",
language = "English",
volume = "6",
pages = "347--353",
journal = "International Journal of Pediatric Hematology/Oncology",
issn = "1070-2903",
publisher = "Taylor and Francis Ltd.",
number = "5",

}

TY - JOUR

T1 - Treatment of neutropenia with intravenous immunoglobulin in autoimmune neutropenia of childhood

AU - Chen, S. H.

AU - Liang, D. C.

AU - Liu, H. C.

AU - Lin, M.

PY - 2000

Y1 - 2000

N2 - Five patients (2 boys, 3 girls) with autoimmune neutropenia (AIN) which developed mainly in infancy were treated with intravenous immunoglobulin (IVIG) and followed up for 69-95 months. AIN was proved by positive antineutrophil antibodies detected by a granulocyte agglutination test. Of these five patients, three patients experienced septicemia prior to treatment. These patients also had several episodes of upper respiratory tract infection, acute otitis media, skin infection and enterocolitis. Basically, IVIG 2 g/kg was given intravenously for each course of treatment. The neutrophil counts increased significantly in all patients with the initial IVIG therapy and two patients went into remission. Subsequent infusions also caused neutrophil counts to increase. Although many patients with AIN have a benign course, those who have significant infections could be treated, acutely or preventively, with IVIG.

AB - Five patients (2 boys, 3 girls) with autoimmune neutropenia (AIN) which developed mainly in infancy were treated with intravenous immunoglobulin (IVIG) and followed up for 69-95 months. AIN was proved by positive antineutrophil antibodies detected by a granulocyte agglutination test. Of these five patients, three patients experienced septicemia prior to treatment. These patients also had several episodes of upper respiratory tract infection, acute otitis media, skin infection and enterocolitis. Basically, IVIG 2 g/kg was given intravenously for each course of treatment. The neutrophil counts increased significantly in all patients with the initial IVIG therapy and two patients went into remission. Subsequent infusions also caused neutrophil counts to increase. Although many patients with AIN have a benign course, those who have significant infections could be treated, acutely or preventively, with IVIG.

KW - Autoimmune neutropenia

KW - Intravenous immunoglobulin

KW - IVIG

UR - http://www.scopus.com/inward/record.url?scp=0033952371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033952371&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033952371

VL - 6

SP - 347

EP - 353

JO - International Journal of Pediatric Hematology/Oncology

JF - International Journal of Pediatric Hematology/Oncology

SN - 1070-2903

IS - 5

ER -